METZGER MICHAEL A (President and COO) sold 34.5% of their position (157.31K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $2.58M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/8/2025ACC: 0000950170-25-113659
Officer· President and COO
Since Feb 2019
+157.31K
Net shares
Net buyer
$2.58M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
314.61K acquired · 157.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+157.31K
Price / share
$10.90
Trade value
$1.71M
% of position
52.7%
9/8/2025
298.66K→455.97K
Common Stock
Direct
Shares
−157.31K
Price / share
$16.41
Trade value
$2.58M
% of position
34.5%
9/8/2025
455.97K→298.66K
Total
Net shares
+0.00
Net value
-$867.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/8/2025 | M · Option Exercise | +157.31K | $10.90 | $1.71M | 52.7% | 298.66K | 455.97K |
| Common Stock Direct | 9/8/2025 | S · Sale | −157.31K | $16.41 | $2.58M | 34.5% | 455.97K | 298.66K |
| Total | +0.00 | -$867.38K | ||||||
Derivative Transactions1
Stock options (Right to buy)
Direct
Converts to
Common Stock
157.31K shares
Shares
+157.31K
Strike price
10.90
Held after
0.00
Exercisable
—
9/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock options (Right to buy) Direct | Common Stock157.31K shares | 9/8/2025 | M · Option Exercise | +157.31K | 10.90 | — | 0.00 |